THYROCARE — Thyrocare Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹33.70bn
- IN₹32.63bn
- IN₹5.72bn
- 98
- 22
- 73
- 75
Annual cashflow statement for Thyrocare Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,465 | 1,525 | 2,279 | 874 | 956 |
| Depreciation | |||||
| Non-Cash Items | 2.2 | -56.7 | -124 | 259 | 239 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -110 | -611 | -1,360 | -227 | 11.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,676 | 1,160 | 1,134 | 1,293 | 1,676 |
| Capital Expenditures | -99 | -283 | -378 | -437 | -616 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 109 | -220 | 143 | 46.6 | -297 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 9.5 | -502 | -236 | -390 | -913 |
| Financing Cash Flow Items | -285 | -7.1 | -47.5 | -13.3 | -54.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,648 | -616 | -894 | -862 | -848 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 38 | 42.4 | 4.3 | 41.4 | -84.7 |